June 12, 2018
Rose
Paris-based Sensome, a company that makes sensors to identify biological tissues, just landed $5.4 million (4.6 euro) in a funding round led by Kurma Partners. The latest funding is expected to help the startup bring its smart stroke guidewire, the Clotild, to market. “This financing round will enable us to bring Clotild through clinical testing and to the European market, and to explore the next applications of our technology,” Franz Bozsak, CEO and cofounder of Sensome, said in a statement.
from MobiHealthNews https://ift.tt/2HGQegf
June 12, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Parachute Health raises $5.5M to digitize 'archaic' medical equipment orders- FDA to Opternative: Online eye exams are a Class 2 device
- Noninvasive injection detection system iSenz completes validation trials, seeks commercialization
- Blink Health sues competitor Hippo Technologies, alleges 'copycat scheme'
- Fitbit adds videogame exec to its board, and other digital health hires
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment